
|Articles|August 31, 2016
Supplements and Featured Publications
- Evaluation of Clinical Outcomes and Costs Based on Prescribed Dose Level of Renin-Angiotensin-Aldost
- Volume 22
- Issue 11
eAppendix
Advertisement
Articles in this issue
Newsletter
Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on AJMC
1
Hereditary Ovarian Cancer Genes Found Beyond Traditionally High-Risk Groups
2
ASH 2025 Offers Data That Could Make Novel Therapies More Accessible
3
Medicaid Expansion Associated With Lower Mortality in NSCLC
4
ACIP Delayed Hepatitis B Vaccine Schedule Vote Amid Safety Controversy
5














































